{
  "ticker": "LH",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T08:01:13.559986",
  "count": 30,
  "transactions": [
    {
      "id": 53206,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 73955,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 34953,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 53207,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 73956,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 34908,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 34939,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 53161,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 53192,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 73910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 73941,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 34924,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 53177,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 73926,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 20319,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 34911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 53164,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 73913,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 20307,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 20321,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 20346,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 34898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 34913,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 34940,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 53151,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 53166,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 53193,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 73900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 73915,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 73942,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    }
  ]
}